检测和药物开发技术 SCIE

期刊简介预计审稿时间： 12周，或约稿

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

《分析和药物开发技术》提供了新技术和强大工具，可实现早期筛选的关键进展。本期刊上发表的这项研究为药物发现和开发提供了重要的治疗方法和平台。这本享有盛誉的同行评审期刊刊登原创论文、应用型技术评论、新兴研究领域的专题以及方法和技术应用报告。

分析和药物开发技术报道包括：

-分析设计、靶标开发和高通量技术-

通过临床前候选药物选择实现先导化合物优化和药物化学-

实验室自动化、样品管理、生物信息学、数据挖掘、虚拟筛选和数据分析-

针对基因家族、遗传和传染病配置的分析方法-

使模型生物适应药物发现的分析和策略-

使用干细胞作为疾病模型-

将表型输出转化为靶标识别-

分析和筛选制品的技术基础探索和机制研究

《Assay And Drug Development Technologies》(检测和药物开发技术)编辑部通讯方式为MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。